Literature DB >> 16005389

A prospective 3-year longitudinal study of cognitive predictors of relapse in first-episode schizophrenic patients.

Eric Yu-Hai Chen1, Christy Lai-Ming Hui, Eva Lai-Wah Dunn, May Yin-King Miao, Wai-Song Yeung, Chi-Keung Wong, Wah-Fat Chan, Wai-Nang Tang.   

Abstract

BACKGROUND: Cognitive predictors of relapse have been extensively explored only in few long term longitudinal studies of first-episode schizophrenia.
METHOD: This study prospectively followed 93 patients with first-episode schizophrenia, schizophreniform disorder, and schizoaffective disorder for 3 years after their first-episode illness. Cognitive domains including verbal intelligence, verbal and visual memory, verbal fluency, and Wisconsin Card Sorting Test performance were investigated as potential predictors of relapse.
RESULTS: We found that by the first year 21% patients had relapsed, by the second year 33% had relapsed, and by the third year 40% had relapsed. There was a significant difference in the relapse rate between patients with good adherence and patients with poor adherence to medication regimes. A multiple logistic regression analysis revealed that after controlling for medication adherence, perseverative error in the Wisconsin Card Sorting Test was the only cognitive function that significantly predict relapse with an odds ratio of 2.4.
CONCLUSIONS: Cognitive flexibility in set shifting is related to tendency towards relapse in first-episode schizophrenic patients. Other cognitive factors appear not to be related to relapse. Possible mechanisms included the link between prefrontal dysfunction and sub-cortical dopamine system stability, as well as the effects of executive dysfunction on insight impairment and adherence behavior.

Entities:  

Mesh:

Year:  2005        PMID: 16005389     DOI: 10.1016/j.schres.2005.02.020

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  35 in total

1.  The RAISE Connection Program for Early Psychosis: Secondary Outcomes and Mediators and Moderators of Improvement.

Authors:  Leslie Marino; Ilana Nossel; Jean C Choi; Keith Nuechterlein; Yuanjia Wang; Susan Essock; Melanie Bennett; Karen McNamara; Sapna Mendon; Lisa Dixon
Journal:  J Nerv Ment Dis       Date:  2015-05       Impact factor: 2.254

2.  Predictors of relapse in Chinese schizophrenia patients: a prospective, multi-center study.

Authors:  Yu-Tao Xiang; Chuan-Yue Wang; Yong-Zhen Weng; Qi-Jing Bo; Helen F K Chiu; Sandra S M Chan; Edwin H M Lee; Gabor S Ungvari
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-11-03       Impact factor: 4.328

3.  Social cognitive training for schizophrenia: a meta-analytic investigation of controlled research.

Authors:  Matthew M Kurtz; Christi L Richardson
Journal:  Schizophr Bull       Date:  2011-04-27       Impact factor: 9.306

4.  Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia.

Authors:  Kenneth L Subotnik; Keith H Nuechterlein; Joseph Ventura; Michael J Gitlin; Stephen Marder; Jim Mintz; Gerhard S Hellemann; Leslie A Thornton; Indira R Singh
Journal:  Am J Psychiatry       Date:  2011-01-04       Impact factor: 18.112

5.  Can a digital medicine system improve adherence to antipsychotic treatment?

Authors:  D Papola; C Gastaldon; G Ostuzzi
Journal:  Epidemiol Psychiatr Sci       Date:  2018-03-12       Impact factor: 6.892

Review 6.  Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia.

Authors:  Ikwunga Wonodi; Robert Schwarcz
Journal:  Schizophr Bull       Date:  2010-02-10       Impact factor: 9.306

7.  Guanfacine Augmentation of a Combined Intervention of Computerized Cognitive Remediation Therapy and Social Skills Training for Schizotypal Personality Disorder.

Authors:  Margaret M McClure; Fiona Graff; Joseph Triebwasser; Mercedes Perez-Rodriguez; Daniel R Rosell; Harold Koenigsberg; Erin A Hazlett; Larry J Siever; Philip D Harvey; Antonia S New
Journal:  Am J Psychiatry       Date:  2019-01-18       Impact factor: 18.112

Review 8.  Psychopharmacological treatment of neurocognitive deficits in people with schizophrenia: a review of old and new targets.

Authors:  Anthony O Ahmed; Ishrat A Bhat
Journal:  CNS Drugs       Date:  2014-04       Impact factor: 5.749

9.  Asenapine restores cognitive flexibility in rats with medial prefrontal cortex lesions.

Authors:  David S Tait; Hugh M Marston; Mohammed Shahid; Verity J Brown
Journal:  Psychopharmacology (Berl)       Date:  2008-10-17       Impact factor: 4.530

10.  Context processing in schizotypal personality disorder: evidence of specificity of impairment to the schizophrenia spectrum.

Authors:  Margaret M McClure; Deanna M Barch; Janine D Flory; Philip D Harvey; Larry J Siever
Journal:  J Abnorm Psychol       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.